BeyondSpring Inc. Contract with Customer, Liability, Noncurrent
BeyondSpring Inc. (BYSI) had Contract with Customer, Liability, Noncurrent of $29.48 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2026-08-14
- 2026-06-30: Contract with Customer, Liability, Noncurrent $29.48M.
- 2026-03-31: Contract with Customer, Liability, Noncurrent $28.99M.
- 2025-12-31: Contract with Customer, Liability, Noncurrent $28.60M.
- 2025-09-30: Contract with Customer, Liability, Noncurrent $28.09M.
| Period end | Contract with Customer, Liability, Noncurrent | Contract with Customer, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $29.48M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $28.99M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $28.60M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $28.09M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $27.92M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $27.56M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $27.40M 10-K · filed 2026-03-25 | |
| 2024-06-30 | $32.34M 6-K · filed 2024-08-29 | |
| 2023-12-31 | $28.17M 10-K · filed 2025-03-27 | $33.24M 6-K · filed 2024-08-29 |
| 2023-06-30 | $33.53M 6-K · filed 2024-02-02 | |
| 2022-12-31 | $34.22M 6-K · filed 2024-02-02 | |
| 2022-06-30 | $35.76M 6-K · filed 2023-02-28 | |
| 2021-12-31 | $37.94M 20-F · filed 2023-04-18 | |
| 2021-09-30 | $37.77M 6-K · filed 2021-12-30 | |
| 2021-06-30 | $7.25M 6-K · filed 2021-09-10 | |
| 2021-03-31 | $7.59M 6-K · filed 2021-06-16 | |
| 2020-12-31 | $7.92M 20-F · filed 2022-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |